# Abbott Laboratories (ABT) — Q2-2024 Earnings Results

**Report date:** 2024-07-18 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABT/earnings/Q2-2024

## Post-Earnings Brief

### Headline

Abbott Labs Beats on EPS, Stock Down 4.4%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.14 | N/A | +3.54% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism regarding future performance. They emphasized their commitment to innovation and adapting to market conditions.

**Key quotes:**

> Management highlighted the resilience of their product portfolio despite market challenges.

> They acknowledged ongoing pressures but expressed confidence in long-term growth strategies.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Abbott Labs reported a slight earnings beat, which indicates some strength in their operations. However, the stock fell 4.4% in reaction, likely due to the lack of revenue data and guidance. Investors may be concerned about future growth prospects given the current market environment.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABT/earnings/Q2-2024_